✦ LIBER ✦

Safety and Long-Term Efficacy of Eculizumab in a Renal Transplant Patient with Recurrent Atypical Hemolytic–Uremic Syndrome

✍ Scribed by V. Chatelet; V. Frémeaux-Bacchi; T. Lobbedez; M. Ficheux; B. Hurault de Ligny

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Eculizumab: Safety and Efficacy After 17

✍ V. Châtelet; T. Lobbedez; V. Frémeaux-Bacchi; M. Ficheux; J.Ph. Ryckelynck; B. H 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 455 KB

Efficacy of eculizumab in a patient with

✍ Anne-Laure Lapeyraque; Véronique Frémeaux-Bacchi; Pierre Robitaille 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 308 KB

CYTOMEGALOVIRUS ASSOCIATED ATYPICAL HEMO

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Recurrent Atypical Hemolytic Uremic Synd

✍ Micah R. Chan; Christie P. Thomas; Jose R. Torrealba; Arjang Djamali; Luis A. Fe 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 443 KB

Immunogenicity of meningococcus C vaccin

✍ Manuela Zlamy; Johannes Hofer; Johannes Elias; Ulrich Vogel; Matthias Frosch; Th 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Interim analysis of phase II efficacy an

✍ T.H.J. Goodship; P. Muus; C. Legendre; K. Douglas; M. Hourmant; Y. Delmas; M. He 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 65 KB